Clinical Trial

Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults

Study acronym: MUCILA
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To assess the efficacy of preventive Low-Level Laser Therapy (LLLT) for reducing the incidence of WHO's grade 3-4 oral mucositis in children and young adults receiving chemotherapy regimens associated with a high rate of mucositis: conventional chemotherapy or High Dose Chemotherapy (HDC) conditioning regimens with Hematological Stem Cell Transplantation (HSCT).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2019-06-11; most recent amendment 2026-02-05.
Status change: Active, Not Recruiting → Recruiting 2021-02-23
Trial Details
NCT Number NCT03983369
Lead Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Conditions Mucositis Oral
Enrollment 315 participants
Start Date 2018-08-29
Primary Completion 2026-08-28 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-02-06